Optimizing LNP Design, Formulation, Characterization & Manufacturing to Deliver Stable, Selective & Targeted RNA, Cell & Genetic Therapeutics in the Liver & Beyond
Landmark clinical successes such as Moderna's positive Phase III melanoma data, alongside major investments from Johnson & Johnson and Eli Lilly, have reinforced confidence in LNPs as the leading non-viral delivery platform. As developers expand into gene editing, in vivo cell therapies, oncology, and genetic medicine, the focus is shifting from proving the potential of LNPs to overcoming the challenges that stand between promising candidates and clinical success.
However, as the field matures, developers face a new set of challenges. Achieving reliable delivery beyond the liver, proving tissue-specific targeting, generating predictive analytical data, and scaling increasingly complex formulations remain critical barriers to success. As investment and clinical activity accelerate, the industry needs practical solutions to translate innovation into approved therapies.
That's why the 6th Lipid Nanoparticles Summit US returns in 2027, evolved and enhanced as the world’s definitive LNP forum, uniting the communities of the LNP Formulation & Process Development, LNP Characterization & Analytical Development, and Extra-Hepatic Delivery Summits under one roof for the first time. Join 200+ formulation, analytical development, process development, delivery, and CMC leaders to benchmark strategies, learn from the latest advances, and accelerate the development of stable, targeted, and scalable LNP therapeutics.
It was one of the best conferences related to LNP that I have attended.
Scientist, Kite Pharma
The speed networking was the best part, it breaks the awkwardness of meeting new people
Senior Modality Expert, Merck
The quality of research presented in this conference is amazing
Senior Director - Operations, Abogen Biosciences
Explore the Full Event Guide
- Explore exclusive insights and sessions covering formulation, extra-hepatic delivery, analytical development, and CMC
- Discover the latest strategies for targeted delivery, proving tissue-specific uptake, and advancing beyond the liver
- Preview case studies from leading organizations including GSK, Sanofi, AbbVie, AstraZeneca, and ModeX Therapeutics
- Discover practical insights on scaling LNPs from discovery through clinical development and commercial manufacturing
- Share with colleagues to evaluate the content streams, sessions, speakers, and networking opportunities most relevant to your team
Speakers
Sorry, we couldn't find any posts. Please try a different search.
Official Partners
Lead Partner
Expertise Partners
Exhibition Partners
Innovation Partner
Attending Companies Include
Explore the Agenda
Discover the latest advances in targeted delivery, analytical development, process scale-up, and CMC readiness through expert-led presentations, interactive discussions, and real-world case studies from leading LNP developers.
Partner With Us
Position your organization at the heart of the LNP community and connect with formulation, analytical, delivery, process development, and CMC leaders actively seeking solutions to accelerate their pipelines and overcome development challenges.
Join LNP Leaders
Connect with scientists and decision-makers from organizations including GSK, Sanofi, AbbVie, AstraZeneca, Alnylam Pharmaceuticals, and Bristol Myers Squibb, and build relationships across the full LNP development ecosystem during dedicated networking opportunities.